Medaus Recalls Zinc Sulfate Vials Due to Sterility Concerns
Medaus, Inc. is recalling specific lots of Zinc Sulfate 10mg/mL vials because the company cannot guarantee the product is sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant risk such as lack of sterility in a medical product is categorized as Severe.
Plain-English summary
Medaus, Inc. is recalling specific lots of Zinc Sulfate 10mg/mL (PF) vials, 2mL size, due to a lack of assurance of sterility. The affected product is identified by the following lot numbers and expiration dates: Lot 151203-53 (BUD 05/31/16), Lot 151217-38 (BUD 06/14/16), and Lot 160208-36 (BUD 08/06/16).
The recall was initiated because the manufacturer could not ensure that the product remained sterile. The source text does not report any specific illnesses, injuries, or deaths associated with this recall.
The product was distributed nationwide in the United States, as well as in Japan and New Zealand. Consumers and healthcare providers should check their inventory for these specific lot numbers and stop using the product if it matches the recalled lots.
The recalled product
- Product
- ZINC SO4 10MG/ML (PF), Vials 2ML, MEDAUS PHARMACY
- Manufacturer
- Medaus, Inc.
- Category
- Drug — Pharmaceutical
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: 151203-53
- BUD: 05/31/16
- Lot #: 151217-38
- BUD: 06/14/16
- Lot #: 160208-36
- BUD: 08/06/16
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 88 recalled by Medaus, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 88 products in this recall →Related recalls
Same manufacturer · Medaus, Inc.
See all →- SevereMedaus Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls Taurine Vials Due to Lack of Sterility Assurance
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls Lipo-Injection Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-07-20
- SevereMedaus Recalls B-Complex Vials Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29